Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.
about
Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitorsThe effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesHumoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA).CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.Rational clinical trial design for antibody mediated renal allograft injury.Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.Immunotherapeutic implication of IL-6 blockade.To B or not to B the conductor of rheumatoid arthritis orchestra.Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.Atacicept as an investigated therapy for rheumatoid arthritis.Achieving incompatible transplantation through desensitization: current perspectives and future directions.The role and therapeutic targeting of IL-6 in rheumatoid arthritis.Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responsesCan IL-6 blockade rectify imbalance between Tregs and Th17 cells?[Methotrexate as combination partner of TNF inhibitors and tocilizumab: what is reasonable from an immunological viewpoint?].Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.
P2860
Q26824294-5E698DB2-E27C-4B4A-A7A1-6D24628E18ABQ26824970-E4847AEA-FFE6-4BD3-B428-00EE3639C777Q27022645-FCA39381-BEE0-4CC2-925C-D938EF6C475FQ35350912-772A8283-822D-4101-AE00-8EABDAD28AD3Q35555943-B3BEC99F-F634-4B9C-B8A8-89DAAD0B5CFCQ36173541-7616CEE6-9308-4873-A122-D0FDFF853BB0Q36761844-545C1803-C60C-411F-A34A-26C640090027Q37965754-09294439-EB14-4AF8-B263-B52F1287E7F3Q38020364-DC1DE2A8-255C-4A12-A3D0-D94A4E384F4AQ38058508-B54BBED7-9FFF-4E14-AC30-AA39A11B6F4AQ38197519-9C07C4B8-11EC-4AAF-B446-A86403AFEFE1Q38235570-24D7A7FC-1341-4D09-82F8-227355619AC3Q38445336-B9A727CE-2693-4B5E-B64A-6CEFAF6EB4C3Q38685086-1E940EBC-3E81-4F3C-8F87-F71A43B1029AQ38826459-0B8D2E78-7F91-491B-B905-A73334B0F6CFQ42561719-026179A2-2A99-4622-84C5-F5B1790B8452Q44212684-A6E275D5-E846-456A-B440-B9B18B640E3DQ44444628-1618A1EC-3D7A-475F-A669-08CD6985BA3EQ45032600-013220CE-D9FD-4374-823B-A67AE91BD9F7
P2860
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@en
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@nl
type
label
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@en
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@nl
prefLabel
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@en
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@nl
P2093
P356
P1476
Impact of IL-6 receptor inhibi ...... l targeting in memory B cells.
@en
P2093
Khalid Muhammad
Petra Roll
Stefan Kleinert
Thomas Dörner
Thomas Seibold
P304
P356
10.1136/ARD.2010.141325
P407
P577
2011-05-08T00:00:00Z